Smoke Testing Page 30 June 2025 Making early AD trials feasible 24 June 2025 ICON named to TIME World's Most Sustainable Companies 2025 list 18 June 2025 The Evolving Cost-Benefit Landscape of Biosimilar Drug Development 30 June 2025 Regulatory Strategy, The Maestro 16 June 2025 NHS App to match patients with clinical trials under 10-year health plan 13 June 2025 Exploring updates in adaptive trial safety monitoring 01 July 2025 Preparing to Achieve with Joint Clinical Assessments 11 June 2025 AI is already delivering pharma value — and not just in drug discovery 10 June 2025 Yearly Trends in Coverage Rates for GLP-1 RAs in Weight Loss 09 June 2025 Tackling the next frontier in metabolic trials: A Q&A with ICON experts Smoke Testing Page Title Subtitle Main body text Title Subtitle Main body text /insights/blog/2020/03/20/juvenile-arthritis-awaren
